Regentis BiomaterialsRGNT
13F holders, Q4 2025 (December 31)3holders
1famous investor
$6.73avg. 13F price*
At the end of Q4 2025, 3 institutions reported holding Regentis Biomaterials Ltd. (RGNT) in their 13F filings. The largest holders were Rosalind Advisors, Inc. ($1.7M), Warberg Asset Management LLC ($127K) and Citadel Advisors ($70K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Regentis Biomaterials Ltd.
- CUSIP
- M8211G108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $1.9M |
| Exits | 0 | $0 |
Ownership 3 holders
| Rosalind Advisors, Inc. | 0.62% | New | 251,510 | $1.7M |
| Warberg Asset Management LLC | 0.40% | New | 19,093 | $127K |
| Citadel Advisors | 0.00% | New | 10,412 | $70K |
"% of holder's portfolio" is RGNT's weight in each manager's 13F, not the share of Regentis Biomaterials Ltd. the manager owns.